Micrometastases in neuroblastoma: are they clinically important? - Wikidata - awgldk - TriplyDB

Micrometastases in neuroblastoma: are they clinically important?

Micrometastases in neuroblastoma: are they clinically important?

http://www.wikidata.org/entity/Q35615459

about

High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma Revisions to the International Neuroblastoma Response Criteria: A Consensus Statement From the National Cancer Institute Clinical Trials Planning Meeting.Novel Platinum(II) compounds modulate insulin-degrading enzyme activity and induce cell death in neuroblastoma cells.The metastatic microenvironment: lung-derived factors control the viability of neuroblastoma lung metastasis.Bone marrows from neuroblastoma patients: an excellent source for tumor genome analyses PHOX2B is a suppressor of neuroblastoma metastasis Minimal metastatic disease.Clinical Significance of Tyrosine Hydroxylase mRNA Transcripts in Peripheral Blood at Diagnosis in Patients with Neuroblastoma.Lack of immunocytological GD2 expression on neuroblastoma cells in bone marrow at diagnosis, during treatment, and at recurrence.

P2860

Q24186636-E570BB16-B15D-4B5D-B57C-473CF549828F Q24200296-A574421D-BB14-44FB-B303-CA805F457AB5 Q24235309-2E289096-28D5-4A9B-A2F3-C335DDAB20E6 Q38804821-B41939A6-B353-4507-969C-016D6539AB80 Q38934781-ABA74E45-9D47-4B55-9D6B-8C5A4692476A Q39155464-E069B332-3ECC-4478-AD2D-B2F7059BFE1D Q41135966-895B13E3-9015-486A-AE26-984346138733 Q42744226-E48719AD-0492-4F70-AC66-CCE16D6CB7FF Q43010886-10E646A0-E936-4007-9D9E-7C6902A1AB99 Q51768675-F9CE09BB-EFAA-490B-A2E9-965415362152 Q53024372-063C118C-0444-45BB-8C0E-80C435C22C65

P2860

Micrometastases in neuroblastoma: are they clinically important?

http://www.wikidata.org/entity/Q35615459

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Micrometastases in neuroblastoma: are they clinically important?

@ast

Micrometastases in neuroblastoma: are they clinically important?

@en

type

label

Micrometastases in neuroblastoma: are they clinically important?

@ast

Micrometastases in neuroblastoma: are they clinically important?

@en

prefLabel

Micrometastases in neuroblastoma: are they clinically important?

@ast

Micrometastases in neuroblastoma: are they clinically important?

@en

P1433

Q35615459-CE93FB03-CB23-4F8F-B75F-26DAC6222DC0

P1476

Q35615459-FDB8D5EC-0A65-4791-9E83-A50B4DC6C746

P2093

Q35615459-D11606FE-FE87-4BCD-B481-81FEC2C611A5

P2860

Q35615459-030583A7-FA81-4B32-8EDD-1BA32CF04577

Q35615459-0688A987-92D6-45D6-A8C7-1C46D5F86D10

Q35615459-0AC9158B-FBAF-45E6-88E0-1813F5F9BFC5

Q35615459-0F6F0CB6-86D1-4379-8E92-C52A0B330FC3

Q35615459-12EBB83B-90B9-4A18-B581-59F6CE60A744

Q35615459-14F54F9D-A4C1-4CC7-B30F-B4F93E3795FC

Q35615459-1D6E7F07-F486-44CE-87AA-4BE3BAD93D95

Q35615459-2AF4B083-8FE3-44AC-BB74-1934FC44AC00

Q35615459-36474D67-A2A2-412B-AEF6-960858677887

Q35615459-3F27C12F-08F3-4E14-803B-4B10278C29C7

P304

Q35615459-E45AC178-2F4A-4D93-9332-C600AC292D88

P31

Q35615459-DB2DA9C5-609B-4C48-B410-22F3FCE0D081

Q35615459-cad55358-53f4-4c4d-922b-95272045bc50

P356

Q35615459-553925DD-4AA2-44C7-9835-52DD49E892D0

P407

Q35615459-AAD0D829-17F3-4E70-9FED-E8FD2E4FF1DB

P433

Q35615459-77350404-5869-4084-A1DD-05B0AE80841B

P478

Q35615459-CAA04D7A-F7E6-4AEF-8679-542C9576C749

P577

Q35615459-39C867A9-1181-40C5-AE2A-60DC6134788D

P5875

Q35615459-946458AC-0A14-4F16-8DDC-42B737E715D5

P698

Q35615459-4808ED97-B977-4052-B69E-6D5D2802C1C7

P932

Q35615459-1C6F972D-299B-4000-9A59-D7A16EE599C3

P356

P1433

Journal of Clinical Pathology

P1476

Micrometastases in neuroblastoma: are they clinically important?

@en

P2093

S A Burchill

http://www.w3.org/2001/XMLSchema#string

P2860

Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantation.

Clinical relevance of minimal residual cancer in patients with solid malignancies.

Molecular detection of low-level disease in patients with cancer.

Monoclonal antibodies for detecting bone marrow invasion by neuroblastoma.

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Primary bioassay of human tumor stem cells.

Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection.

Low specificity of PGP9.5 expression for detection of micrometastatic neuroblastoma

The spontaneous regression of neuroblastoma. Experimental evidence for a natural host immunity.

P304

14-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JCP.57.1.14

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2004-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8943415

http://www.w3.org/2001/XMLSchema#string

P698

14693828

http://www.w3.org/2001/XMLSchema#string

P932

1770188

http://www.w3.org/2001/XMLSchema#string